Pracinostat for AML update: follow-up analysis and Phase III trial
Ibrutinib combination regimens for CLL from ASH 2017
The issue of relapse in Philadelphia chromosome-positive ALL patients and how to combat this
CAR T-cells and fast cars
PHILEMON: a step closer to using MRD to guide treatment decisions in mantle cell lymphoma (MCL)?